Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients.
作者： Gang Zhou , Lizhi Niu , David Chiu , Lihua He , Kecheng Xu
DOI: 10.1007/S10529-012-0908-5
关键词:
摘要: … taken from 37 pancreatic cancer patients prior to treatment. Levels of CA242, CA199, CA125, CEA and TNF-α expression correlated with tumor size, clinical stage, tumor differentiation, …
springer.com
sci-hub.se 参考文章(18)
Jing-Ting Jiang, Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer World Journal of Gastroenterology. ,vol. 10, pp. 1675- 1677 ,(2004) , 10.3748/WJG.V10.I11.1675
Andrew A. Gage, John G. Baust, Cryosurgery for Tumors Journal of The American College of Surgeons. ,vol. 205, pp. 342- 356 ,(2007) , 10.1016/J.JAMCOLLSURG.2007.03.007
Christoph W Michalski, Jürgen Weitz, Markus W Büchler, Surgery insight: surgical management of pancreatic cancer. Nature Reviews Clinical Oncology. ,vol. 4, pp. 526- 535 ,(2007) , 10.1038/NCPONC0925
Ke Cheng XU, Li Zhi NIU, Yi Ze HU, Wei Bing HE, Yi Song HE, Jian Sheng ZUO, Cryosurgery with combination of (125)iodine seed implantation for the treatment of locally advanced pancreatic cancer. Journal of Digestive Diseases. ,vol. 9, pp. 32- 40 ,(2008) , 10.1111/J.1443-9573.2007.00322.X
Enrico Giraudo, Luca Primo, Enrica Audero, Hans-Peter Gerber, Pieter Koolwijk, Shay Soker, Michael Klagsbrun, Napoleone Ferrara, Federico Bussolino, None, Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells Journal of Biological Chemistry. ,vol. 273, pp. 22128- 22135 ,(1998) , 10.1074/JBC.273.34.22128
Stephen J. Kovach, Richard J. Hendrickson, Charles R. Cappadona, C.Max Schmidt, Kara Groen, Leonidas G. Koniaris, James V. Sitzmann, Cryoablation of unresectable pancreatic cancer. Surgery. ,vol. 131, pp. 463- 464 ,(2002) , 10.1067/MSY.2002.121231
Vladimir Mouraviev, Thomas J. Polascik, Update on cryotherapy for prostate cancer in 2006. Current Opinion in Urology. ,vol. 16, pp. 152- 156 ,(2006) , 10.1097/01.MOU.0000193393.54598.9F
Byeong-Bae Park, Joon Oh Park, Hyo Rak Lee, Jeeyun Lee, Dong Wook Choi, Seong-Ho Choi, Jin Seok Heo, Jong Kyun Lee, Kyu Taek Lee, Do Hoon Lim, Young Suk Park, Ho-Yeong Lim, Won Ki Kang, Keunchil Park, A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma. Cancer Chemotherapy and Pharmacology. ,vol. 60, pp. 489- 494 ,(2007) , 10.1007/S00280-006-0390-7
D Hartmann, J C Eickhoff, M Möhler, P R Galle, J F Riemann, R Jakobs, A Eickhoff, W Martin, A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma. British Journal of Cancer. ,vol. 94, pp. 1572- 1574 ,(2006) , 10.1038/SJ.BJC.6603174
Michael G. Schlieman, Utility of Tumor Markers in Determining Resectability of Pancreatic Cancer Archives of Surgery. ,vol. 138, pp. 951- 956 ,(2003) , 10.1001/ARCHSURG.138.9.951